INSIGHTS ON DRUG DEVELOPMENT
-
Integrating Phase-Appropriate Quality Standards
Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.
-
Complex Antibody Expression - Challenge Accepted
Explore how tailored cell line development strategies are enabling high-yield production of complex biologics and reveal how automation and data modeling drive success in CHO cell line development.
-
Seed Train Intensification Using High Cell Density Cryopreservation
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Studying The Spatial Architecture Of Glioblastoma
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
Facts About AAV Producer Cell Lines8/8/2025
Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.
-
Safety, Containment, And Analysis Of Highly Potent Compounds5/16/2024
Explore a comprehensive overview of the challenges, requirements, and best practices for safely working with highly potent compounds in drug development and manufacturing.
-
Process Intensification Strategies For Smarter Biomanufacturing10/1/2025
Explore how biopharma leaders are using process intensification to modernize facilities, cut costs, and increase yield with practical strategies and real-world case studies.
-
Multiplex Imaging3/24/2025
Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
-
Success Story: Increased Productivity With Concentrated Fed-Batch6/30/2025
Discover how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.
DRUG DEVELOPMENT SOLUTIONS
-
Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.
-
Standalone instrument with touchscreen and built-in sample ports for small volumes and cuvettes
The SpectraMax® QuickDrop™ Micro-Volume Spectrophotometer quantifies very small amounts of DNA, RNA, oligos, and proteins.
-
Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.
-
Next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types
Demonstrating that cell lines are monoclonal – or that a gene was edited as expected – can be a time-consuming and highly-subjective process when relying on conventional technologies. The CloneSelect® Imager and CloneSelect® Imager FL are a high-throughput automated solutions for imaging and analyzing mammalian cells. Tracking the formation of a colony from a single cell is effortless as barcoded plates are tracked over time. Automated acquisition and analysis provides accurate, objective, and consistent results.
-
Enabling you to design vaccines without reliance on animal sources with our fermentation-produced squalene.